Tonix Pharmaceuticals Holding Corp
TNXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$199.74M
Close$
$12.39
12.1% upside
Current Fair Value
12.1% upsideUndervalued by 12.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $199.74 Million |
|---|---|
| Enterprise Value | $15.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.57 |
| Beta | 1.65 |
| Outstanding Shares | 13,707,104 |
Return
| Return on Equity | -31.79% |
|---|---|
| Return on Assets | -28.00% |
| Return on Invested Capital | -65.77% |
Valuation & Multiples
| P/E Ratio | -0.85 |
|---|---|
| PEG | - |
| Price to Sales | 11.06 |
| Price to Book Ratio | 0.69 |
| Enterprise Value to Revenue | 0.89 |
| Enterprise Value to EBIT | -0.1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-2.54
Average shareholder expectationRevenue Estimate
$6.13 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-2.64
Average shareholder expectationRevenue Estimate
$7.72 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 75.66% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 57.20% |
|---|---|
| Total Invested | $7,121▼ 99.99% |
| Investors Holding | 3▼ 84.00% |
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman